Director/PDMR Shareholding

RNS Number : 6618E

GlaxoSmithKline PLC

19 July 2016

 

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Sir Andrew Witty
b)	Position/status	CEO
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial  instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	Increase in notional interest in Ordinary Shares following the re-investment of dividends paid to shareholders on 14 July 2016 on Ordinary Shares held in the Company's 2009 Performance Share Plan.
c)	Price(s) and volume(s)	Price(s) Volume(s) £16.285 3.975 £16.285 217.131 £16.285 580.125 £16.285 1,329.326 £16.285 3,988.006 £16.285 5,452.053 £16.285 5,905.210
d)	Aggregated information Aggregated volume Price	17,475.826 £16.285
e)	Date of the transaction	2016-07-14
f)	Place of the transaction	n/a

 

END

 

 

DSHDKLFFQDFLBBX